Danaher Corp.
DHR
Market Cap$180.69B
Close$
Earnings Call Q4 2023
January 30, 2024 - AI Summary
Danaher reported better than anticipated core revenue in each of its segments in Q4 2023, led by strong performance in respiratory revenue at Cepheid.
The company exceeded margin and cash flow expectations for the quarter due to higher revenues and strong execution.
Danaher's full-year 2023 sales were $23.9 billion, with a core revenue decline of 10%, including a COVID-19 revenue headwind of approximately 9.5%.
Exclusive for Stockcircle Pro members
Sign up
$219.75
8.2% downside
Current Fair Value
8.2% downsideOvervalued by 8.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $180.69 Billion |
|---|---|
| Enterprise Value | $193.23 Billion |
| Dividend Yield | $1.0483 (0.43%) |
| Earnings per Share | $6.38 |
| Beta | 0.86 |
| Outstanding Shares | 740,544,214 |
| Avg 30 Day Volume | 2,572,047 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 38.1 |
|---|---|
| PEG | -74.44 |
| Price to Sales | 7.48 |
| Price to Book Ratio | 3.32 |
| Enterprise Value to Revenue | 8.09 |
| Enterprise Value to EBIT | 37.15 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
ESG Score
No data
About Danaher Corp.
2,020 employees
CEO: Rainer Blair